Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ketamine for Combined Depression and Alcohol Use Disorder: A Blinded Randomized Active Placebo-controlled Trial (the KeDA Trial)

NCT06090422 is registered in ClinicalTrials.gov with University Hospital of North Norway as lead sponsor.

NCT NCT06090422
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06090422 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ketamine for Combined Depression and Alcohol Use Disorder: A Blinded Randomized Active Placebo-controlled Trial (the KeDA Trial)
Lead sponsor
University Hospital of North Norway
Phase
Phase 1/2
Overall status
Recruiting
Start date
January 20, 2025
Completion date
July 1, 2027
Enrollment
34 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol use disorder, depression